Chemical mechanisms of histone lysine and arginine modifications

Biochimica et Biophysica Acta - Gene Regulatory Mechanisms

Volumn 1789, Issue 1, 2009, Pages 45-57

  Smith, Brian C ^a   Denu, John M ^b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Acetyltransferase; Deacetylase; Deiminase; Demethylase; Methyltransferase; Sirtuin

Indexed keywords

ACETYL COENZYME A; ACYLTRANSFERASE; ARGININE; ARGININE DEIMINASE; ENZYME; HISTONE DEACETYLASE; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE 4; HISTONE LYSINE METHYLTRANSFERASE; IRON; LYSINE; METHYLTRANSFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE; PROTEIN ARGININE DEIMINASE; PROTEIN ARGININE METHYLTRANSFERASE; S ADENOSYLMETHIONINE; ZINC;

CATALYSIS; CHEMICAL MODIFICATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; REVIEW;

ANIMALS; ARGININE; CATALYSIS; CATALYTIC DOMAIN; DNA; HISTONES; HUMANS; LYSINE; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 59349115177     PISSN: 18749399     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagrm.2008.06.005     Document Type: Review

References (166)

1. Kornberg R.D., and Lorch Y. Twenty-five years of the nucleosome, fundamental particle of the eukaryote chromosome. Cell 98 (1999) 285-294
2. Luger K., and Hansen J.C. Nucleosome and chromatin fiber dynamics. Curr. Opin. Struct. Biol. 15 (2005) 188-196
3. Peterson C.L., and Laniel M.A. Histones and histone modifications. Curr. Biol. 14 (2004) R546-R551
4. Suzuki A., Yamada R., and Yamamoto K. Citrullination by peptidylarginine deiminase in rheumatoid arthritis. Ann. N. Y. Acad. Sci. 1108 (2007) 323-339
5. Glozak M.A., and Seto E. Histone deacetylases and cancer. Oncogene 26 (2007) 5420-5432
6. Chen X., Niroomand F., Liu Z., Zankl A., Katus H.A., Jahn L., and Tiefenbacher C.P. Expression of nitric oxide related enzymes in coronary heart disease. Basic Res. Cardiol. 101 (2006) 346-353
7. Longo V.D., and Kennedy B.K. Sirtuins in aging and age-related disease. Cell 126 (2006) 257-268
8. Milne J.C., and Denu J.M. The Sirtuin family: therapeutic targets to treat diseases of aging. Curr. Opin. Chem. Biol. (2008)
9. Anekonda T.S., and Reddy P.H. Neuronal protection by sirtuins in Alzheimer's disease. J. Neurochem. 96 (2006) 305-313
10. Allis C.D., Berger S.L., Cote J., Dent S., Jenuwien T., Kouzarides T., Pillus L., Reinberg D., Shi Y., Shiekhattar R., Shilatifard A., Workman J., and Zhang Y. New nomenclature for chromatin-modifying enzymes. Cell 131 (2007) 633-636
11. Rice J.C., and Allis C.D. Histone methylation versus histone acetylation: new insights into epigenetic regulation. Curr. Opin. Cell Biol. 13 (2001) 263-273
12. Schneider R., Bannister A.J., and Kouzarides T. Unsafe SETs: histone lysine methyltransferases and cancer. Trends Biochem. Sci. 27 (2002) 396-402
13. Van Beekum O., and Kalkhoven E. Aberrant forms of histone acetyltransferases in human disease. Subcell. Biochem. 41 (2007) 233-262
14. Marks P.A., and Breslow R. Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug. Nat. Biotechnol. 25 (2007) 84-90
15. Letunic I., Copley R.R., Schmidt S., Ciccarelli F.D., Doerks T., Schultz J., Ponting C.P., and Bork P. SMART 4.0: towards genomic data integration. Nucleic Acids Res. 32 (2004) D142-144
16. Chin H.G., Patnaik D., Esteve P.O., Jacobsen S.E., and Pradhan S. Catalytic properties and kinetic mechanism of human recombinant Lys-9 histone H3 methyltransferase SUV39H1: participation of the chromodomain in enzymatic catalysis. Biochemistry 45 (2006) 3272-3284
17. Patnaik D., Chin H.G., Esteve P.O., Benner J., Jacobsen S.E., and Pradhan S. Substrate specificity and kinetic mechanism of mammalian G9a histone H3 methyltransferase. J. Biol. Chem. 279 (2004) 53248-53258
18. Guo H.B., and Guo H. Mechanism of histone methylation catalyzed by protein lysine methyltransferase SET7/9 and origin of product specificity. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 8797-8802
19. Derewenda Z.S., Lee L., and Derewenda U. The occurrence of C-H...O hydrogen bonds in proteins. J. Mol. Biol. 252 (1995) 248-262
20. Scheiner S., Kar T., and Gu Y. Strength of the Calpha H...O hydrogen bond of amino acid residues. J. Biol. Chem. 276 (2001) 9832-9837
21. Park H., Yoon J., and Seok C. Strength of Calpha-H...O{double bond, short}C hydrogen bonds in transmembrane proteins. J. Phys. Chem. B 112 (2008) 1041-1048
22. Scheiner S., and Kar T. Effect of solvent upon CH...O hydrogen bonds with implications for protein folding. J. Phys. Chem. B 109 (2005) 3681-3689
23. Hu P., and Zhang Y. Catalytic mechanism and product specificity of the histone lysine methyltransferase SET7/9: an ab initio QM/MM-FE study with multiple initial structures. J. Am. Chem. Soc. 128 (2006) 1272-1278
24. Couture J.F., Hauk G., Thompson M.J., Blackburn G.M., and Trievel R.C. Catalytic roles for carbon-oxygen hydrogen bonding in SET domain lysine methyltransferases. J. Biol. Chem. 281 (2006) 19280-19287
25. Kwon T., Chang J.H., Kwak E., Lee C.W., Joachimiak A., Kim Y.C., Lee J., and Cho Y. Mechanism of histone lysine methyl transfer revealed by the structure of SET7/9-AdoMet. EMBO J. 22 (2003) 292-303
26. Zhang X., Yang Z., Khan S.I., Horton J.R., Tamaru H., Selker E.U., and Cheng X. Structural basis for the product specificity of histone lysine methyltransferases. Mol. Cell. 12 (2003) 177-185
27. Jacobs S.A., Harp J.M., Devarakonda S., Kim Y., Rastinejad F., and Khorasanizadeh S. The active site of the SET domain is constructed on a knot. Nat. Struct. Biol. 9 (2002) 833-838
28. Zhang X., Tamaru H., Khan S.I., Horton J.R., Keefe L.J., Selker E.U., and Cheng X. Structure of the Neurospora SET domain protein DIM-5, a histone H3 lysine methyltransferase. Cell 111 (2002) 117-127
29. Dirk L.M., Flynn E.M., Dietzel K., Couture J.F., Trievel R.C., and Houtz R.L. Kinetic manifestation of processivity during multiple methylations catalyzed by SET domain protein methyltransferases. Biochemistry 46 (2007) 3905-3915
30. Xiao B., Jing C., Kelly G., Walker P.A., Muskett F.W., Frenkiel T.A., Martin S.R., Sarma K., Reinberg D., Gamblin S.J., and Wilson J.R. Specificity and mechanism of the histone methyltransferase Pr-Set7. Genes Dev. 19 (2005) 1444-1454
31. Westheimer F.H. Coincidences, decarboxylation, and electrostatic effects. Tetrahedron 51 (1995) 3-20
32. Cheng X., Collins R.E., and Zhang X. Structural and sequence motifs of protein (histone) methylation enzymes. Annu. Rev. Biophys. Biomol. Struct. 34 (2005) 267-294
33. Qian C., and Zhou M.M. SET domain protein lysine methyltransferases: structure, specificity and catalysis. Cell Mol. Life Sci. 63 (2006) 2755-2763
34. Xiao B., Wilson J.R., and Gamblin S.J. SET domains and histone methylation. Curr. Opin. Struct. Biol. 13 (2003) 699-705
35. Zhang X., and Bruice T.C. Histone lysine methyltransferase SET7/9: formation of a water channel precedes each methyl transfer. Biochemistry 46 (2007) 14838-14844
36. Zhang X., and Bruice T.C. Mechanism of product specificity of AdoMet methylation catalyzed by lysine methyltransferases: transcriptional factor p53 methylation by histone lysine methyltransferase SET7/9. Biochemistry 47 (2008) 2743-2748
37. Esteve P.O., Patnaik D., Chin H.G., Benner J., Teitell M.A., and Pradhan S. Functional analysis of the N- and C-terminus of mammalian G9a histone H3 methyltransferase. Nucleic Acids Res. 33 (2005) 3211-3223
38. Xiao B., Jing C., Wilson J.R., Walker P.A., Vasisht N., Kelly G., Howell S., Taylor I.A., Blackburn G.M., and Gamblin S.J. Structure and catalytic mechanism of the human histone methyltransferase SET7/9. Nature 421 (2003) 652-656
39. Trievel R.C., Flynn E.M., Houtz R.L., and Hurley J.H. Mechanism of multiple lysine methylation by the SET domain enzyme Rubisco LSMT. Nat. Struct. Biol. 10 (2003) 545-552
40. Hu P., Wang S., and Zhang Y. How do SET-domain protein lysine methyltransferases achieve the methylation state specificity? Revisited by ab initio QM/MM molecular dynamics simulations. J. Am. Chem. Soc. (2008)
41. Feng Q., Wang H., Ng H.H., Erdjument-Bromage H., Tempst P., Struhl K., and Zhang Y. Methylation of H3-lysine 79 is mediated by a new family of HMTases without a SET domain. Curr. Biol. 12 (2002) 1052-1058
42. Lacoste N., Utley R.T., Hunter J.M., Poirier G.G., and Cote J. Disruptor of telomeric silencing-1 is a chromatin-specific histone H3 methyltransferase. J. Biol. Chem. 277 (2002) 30421-30424
43. Ng H.H., Feng Q., Wang H., Erdjument-Bromage H., Tempst P., Zhang Y., and Struhl K. Lysine methylation within the globular domain of histone H3 by Dot1 is important for telomeric silencing and Sir protein association. Genes Dev. 16 (2002) 1518-1527
44. van Leeuwen F., Gafken P.R., and Gottschling D.E. Dot1p modulates silencing in yeast by methylation of the nucleosome core. Cell 109 (2002) 745-756
45. Min J., Feng Q., Li Z., Zhang Y., and Xu R.M. Structure of the catalytic domain of human DOT1L, a non-SET domain nucleosomal histone methyltransferase. Cell 112 (2003) 711-723
46. Sawada K., Yang Z., Horton J.R., Collins R.E., Zhang X., and Cheng X. Structure of the conserved core of the yeast Dot1p, a nucleosomal histone H3 lysine 79 methyltransferase. J. Biol. Chem. 279 (2004) 43296-43306
47. Schubert H.L., Blumenthal R.M., and Cheng X. Many paths to methyltransfer: a chronicle of convergence. Trends Biochem. Sci. 28 (2003) 329-335
48. Paik W.K., and Kim S. Enzymatic demethylation of calf thymus histones. Biochem. Biophys. Res. Commun. 51 (1973) 781-788
49. Forneris F., Binda C., Adamo A., Battaglioli E., and Mattevi A. Structural basis of LSD1-CoREST selectivity in histone H3 recognition. J. Biol. Chem. 282 (2007) 20070-20074
50. Forneris F., Binda C., Vanoni M.A., Mattevi A., and Battaglioli E. Histone demethylation catalysed by LSD1 is a flavin-dependent oxidative process. FEBS Lett. 579 (2005) 2203-2207
51. Forneris F., Binda C., Dall'Aglio A., Fraaije M.W., Battaglioli E., and Mattevi A. A highly specific mechanism of histone H3-K4 recognition by histone demethylase LSD1. J. Biol. Chem. 281 (2006) 35289-35295
52. Ghisla S. Fluorescence and optical characteristics of reduced flavins and flavoproteins. Methods Enzymol. 66 (1980) 360-373
53. Culhane J.C., and Cole P.A. LSD1 and the chemistry of histone demethylation. Curr. Opin. Chem. Biol. 11 (2007) 561-568
54. Ralph E.C., Anderson M.A., Cleland W.W., and Fitzpatrick P.F. Mechanistic studies of the flavoenzyme tryptophan 2-monooxygenase: deuterium and 15N kinetic isotope effects on alanine oxidation by an l-amino acid oxidase. Biochemistry 45 (2006) 15844-15852
55. Silverman R.B., Hoffman S.J., and Catus III W.B. A mechanism for mitochondrial monoamine oxidase catalyzed amine oxidation. J. Am. Chem. Soc. 102 (1980) 7126-7128
56. Tsukada Y., Fang J., Erdjument-Bromage H., Warren M.E., Borchers C.H., Tempst P., and Zhang Y. Histone demethylation by a family of JmjC domain-containing proteins. Nature 439 (2006) 811-816
57. Anand R., and Marmorstein R. Structure and mechanism of lysine-specific demethylase enzymes. J. Biol. Chem. 282 (2007) 35425-35429
58. Hausinger R.P. Fe(II)/alpha-ketoglutarate-dependent hydroxylases and related enzymes. Crit. Rev. Biochem. Mol. Biol. 39 (2004) 21-68
59. Ozer A., and Bruick R.K. Non-heme dioxygenases: cellular sensors and regulators jelly rolled into one?. Nat. Chem. Biol. 3 (2007) 144-153
60. Couture J.F., Collazo E., Ortiz-Tello P.A., Brunzelle J.S., and Trievel R.C. Specificity and mechanism of JMJD2A, a trimethyllysine-specific histone demethylase. Nat. Struct. Mol. Biol. 14 (2007) 689-695
61. Ng S.S., Kavanagh K.L., McDonough M.A., Butler D., Pilka E.S., Lienard B.M., Bray J.E., Savitsky P., Gileadi O., von Delft F., Rose N.R., Offer J., Scheinost J.C., Borowski T., Sundstrom M., Schofield C.J., and Oppermann U. Crystal structures of histone demethylase JMJD2A reveal basis for substrate specificity. Nature 448 (2007) 87-91
62. Chen Z., Zang J., Kappler J., Hong X., Crawford F., Wang Q., Lan F., Jiang C., Whetstine J., Dai S., Hansen K., Shi Y., and Zhang G. Structural basis of the recognition of a methylated histone tail by JMJD2A. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 10818-10823
63. Shi Y., and Whetstine J.R. Dynamic regulation of histone lysine methylation by demethylases. Mol. Cell 25 (2007) 1-14
64. Szewczuk L.M., Culhane J.C., Yang M., Majumdar A., Yu H., and Cole P.A. Mechanistic analysis of a suicide inactivator of histone demethylase LSD1. Biochemistry 46 (2007) 6892-6902
65. Grzyska P.K., Ryle M.J., Monterosso G.R., Liu J., Ballou D.P., and Hausinger R.P. Steady-state and transient kinetic analyses of taurine/alpha-ketoglutarate dioxygenase: effects of oxygen concentration, alternative sulfonates, and active-site variants on the FeIV-oxo intermediate. Biochemistry 44 (2005) 3845-3855
66. Roy T.W., and Bhagwat A.S. Kinetic studies of Escherichia coli AlkB using a new fluorescence-based assay for DNA demethylation. Nucleic Acids Res. 35 (2007) e147
67. Wolfe M.D., Altier D.J., Stubna A., Popescu C.V., Munck E., and Lipscomb J.D. Benzoate 1,2-dioxygenase from Pseudomonas putida: single turnover kinetics and regulation of a two-component Rieske dioxygenase. Biochemistry 41 (2002) 9611-9626
68. Ryle M.J., Padmakumar R., and Hausinger R.P. Stopped-flow kinetic analysis of Escherichia coli taurine/alpha-ketoglutarate dioxygenase: interactions with alpha-ketoglutarate, taurine, and oxygen. Biochemistry 38 (1999) 15278-15286
69. Tyihak E., Trezl L., and Szende B. Formaldehyde cycle and the phases of stress syndrome. Ann. N. Y. Acad. Sci. 851 (1998) 259-270
70. Roth S.Y., Denu J.M., and Allis C.D. Histone acetyltransferases. Annu. Rev. Biochem. 70 (2001) 81-120
71. Tanner K.G., Langer M.R., Kim Y., and Denu J.M. Kinetic mechanism of the histone acetyltransferase GCN5 from yeast. J. Biol. Chem. 275 (2000) 22048-22055
72. Tanner K.G., Trievel R.C., Kuo M.H., Howard R.M., Berger S.L., Allis C.D., Marmorstein R., and Denu J.M. Catalytic mechanism and function of invariant glutamic acid 173 from the histone acetyltransferase GCN5 transcriptional coactivator. J. Biol. Chem. 274 (1999) 18157-18160
73. Yan Y., Barlev N.A., Haley R.H., Berger S.L., and Marmorstein R. Crystal structure of yeast Esa1 suggests a unified mechanism for catalysis and substrate binding by histone acetyltransferases. Mol. Cell 6 (2000) 1195-1205
74. Yan Y., Harper S., Speicher D.W., and Marmorstein R. The catalytic mechanism of the ESA1 histone acetyltransferase involves a self-acetylated intermediate. Nat. Struct. Biol. 9 (2002) 862-869
75. Berndsen C.E., Albaugh B.N., Tan S., and Denu J.M. Catalytic mechanism of a MYST family histone acetyltransferase. Biochemistry 46 (2007) 623-629
76. Sagar V., Zheng W., Thompson P.R., and Cole P.A. Bisubstrate analogue structure-activity relationships for p300 histone acetyltransferase inhibitors. Bioorg. Med. Chem. 12 (2004) 3383-3390
77. Thompson P.R., Kurooka H., Nakatani Y., and Cole P.A. Transcriptional coactivator protein p300. Kinetic characterization of its histone acetyltransferase activity. J. Biol. Chem. 276 (2001) 33721-33729
78. Liu X., Wang L., Zhao K., Thompson P.R., Hwang Y., Marmorstein R., and Cole P.A. The structural basis of protein acetylation by the p300/CBP transcriptional coactivator. Nature 451 (2008) 846-850
79. Gregoretti I.V., Lee Y.M., and Goodson H.V. Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis. J. Mol. Biol. 338 (2004) 17-31
80. Frye R.A. Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins. Biochem. Biophys. Res. Commun. 273 (2000) 793-798
81. Imai S., Armstrong C.M., Kaeberlein M., and Guarente L. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 403 (2000) 795-800
82. Hodawadekar S.C., and Marmorstein R. Chemistry of acetyl transfer by histone modifying enzymes: structure, mechanism and implications for effector design. Oncogene 26 (2007) 5528-5540
83. Somoza J.R., Skene R.J., Katz B.A., Mol C., Ho J.D., Jennings A.J., Luong C., Arvai A., Buggy J.J., Chi E., Tang J., Sang B.C., Verner E., Wynands R., Leahy E.M., Dougan D.R., Snell G., Navre M., Knuth M.W., Swanson R.V., McRee D.E., and Tari L.W. Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases. Structure 12 (2004) 1325-1334
84. Vannini A., Volpari C., Filocamo G., Casavola E.C., Brunetti M., Renzoni D., Chakravarty P., Paolini C., De Francesco R., Gallinari P., Steinkuhler C., and Di Marco S. Crystal structure of a eukaryotic zinc-dependent histone deacetylase, human HDAC8, complexed with a hydroxamic acid inhibitor. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 15064-15069
85. Vannini A., Volpari C., Gallinari P., Jones P., Mattu M., Carfi A., De Francesco R., Steinkuhler C., and Di Marco S. Substrate binding to histone deacetylases as shown by the crystal structure of the HDAC8-substrate complex. EMBO Rep. 8 (2007) 879-884
86. Gantt S.L., Gattis S.G., and Fierke C.A. Catalytic activity and inhibition of human histone deacetylase 8 is dependent on the identity of the active site metal ion. Biochemistry 45 (2006) 6170-6178
87. Corminboeuf C., Hu P., Tuckerman M.E., and Zhang Y. Unexpected deacetylation mechanism suggested by a density functional theory QM/MM study of histone-deacetylase-like protein. J. Am. Chem. Soc. 128 (2006) 4530-4531
88. Vanommeslaeghe K., De Proft F., Loverix S., Tourwe D., and Geerlings P. Theoretical study revealing the functioning of a novel combination of catalytic motifs in histone deacetylase. Bioorg. Med. Chem. 13 (2005) 3987-3992
89. Fischle W., Dequiedt F., Hendzel M.J., Guenther M.G., Lazar M.A., Voelter W., and Verdin E. Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR. Mol. Cell 9 (2002) 45-57
90. Schultz B.E., Misialek S., Wu J., Tang J., Conn M.T., Tahilramani R., and Wong L. Kinetics and comparative reactivity of human class I and class IIb histone deacetylases. Biochemistry 43 (2004) 11083-11091
91. Sengupta N., and Seto E. Regulation of histone deacetylase activities. J. Cell. Biochem. 93 (2004) 57-67
92. Jackson M.D., and Denu J.M. Structural identification of 2′- and 3′-O-acetyl-ADP-ribose as novel metabolites derived from the Sir2 family of beta-NAD+-dependent histone/protein deacetylases. J. Biol. Chem. 277 (2002) 18535-18544
93. Sauve A.A., Celic I., Avalos J., Deng H., Boeke J.D., and Schramm V.L. Chemistry of gene silencing: the mechanism of NAD+-dependent deacetylation reactions. Biochemistry 40 (2001) 15456-15463
94. Borra M.T., Langer M.R., Slama J.T., and Denu J.M. Substrate specificity and kinetic mechanism of the Sir2 family of NAD+-dependent histone/protein deacetylases. Biochemistry 43 (2004) 9877-9887
95. Avalos J.L., Boeke J.D., and Wolberger C. Structural basis for the mechanism and regulation of Sir2 enzymes. Mol. Cell 13 (2004) 639-648
96. Zhao K., Harshaw R., Chai X., and Marmorstein R. Structural basis for nicotinamide cleavage and ADP-ribose transfer by NAD(+)-dependent Sir2 histone/protein deacetylases. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 8563-8568
97. Jackson M.D., Schmidt M.T., Oppenheimer N.J., and Denu J.M. Mechanism of nicotinamide inhibition and transglycosidation by Sir2 histone/protein deacetylases. J. Biol. Chem. 278 (2003) 50985-50998
98. Landry J., Sutton A., Tafrov S.T., Heller R.C., Stebbins J., Pillus L., and Sternglanz R. The silencing protein SIR2 and its homologs are NAD-dependent protein deacetylases. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 5807-5811
99. Sauve A.A., and Schramm V.L. Sir2 regulation by nicotinamide results from switching between base exchange and deacetylation chemistry. Biochemistry 42 (2003) 9249-9256
100. Smith B.C., and Denu J.M. Sir2 protein deacetylases: evidence for chemical intermediates and functions of a conserved histidine. Biochemistry 45 (2006) 272-282
101. Smith B.C., and Denu J.M. Mechanism-based inhibition of sir2 deacetylases by thioacetyl-lysine peptide. Biochemistry 46 (2007) 14478-14486
102. Hoff K.G., Avalos J.L., Sens K., and Wolberger C. Insights into the sirtuin mechanism from ternary complexes containing NAD+ and acetylated peptide. Structure 14 (2006) 1231-1240
103. Khan A.N., and Lewis P.N. Use of substrate analogs and mutagenesis to study substrate binding and catalysis in the Sir2 family of NAD-dependent protein deacetylases. J. Biol. Chem. 281 (2006) 11702-11711
104. Smith B.C., and Denu J.M. Sir2 deacetylases exhibit nucleophilic participation of acetyl-lysine in NAD+ cleavage. J. Am. Chem. Soc. 129 (2007) 5802-5803
105. Berti P.J., Blanke S.R., and Schramm V.L. Transition state structure for the hydrolysis of NAD+ catalyzed by diphtheria toxin. J. Am. Chem. Soc. 119 (1997) 12079-12088
106. Parikh S.L., and Schramm V.L. Transition state structure for ADP-ribosylation of eukaryotic elongation factor 2 catalyzed by diphtheria toxin. Biochemistry 43 (2004) 1204-1212
107. Rising K.A., and Schramm V.L. Transition state analysis of NAD+ hydrolysis by the cholera toxin catalytic subunit. J. Am. Chem. Soc. 119 (1997) 27-37
108. Scheuring J., Berti P.J., and Schramm V.L. Transition-state structure for the ADP-ribosylation of recombinant gia1 subunits by pertussis toxin. Biochemistry 37 (1998) 2748-2758
109. Scheuring J., and Schramm V.L. Pertussis toxin: transition state analysis for ADP-ribosylation of G-protein peptide alphai3C20. Biochemistry 36 (1997) 8215-8223
110. Scheuring J., and Schramm V.L. Kinetic isotope effect characterization of the transition state for oxidized nicotinamide adenine dinucleotide hydrolysis by pertussis toxin. Biochemistry 36 (1997) 4526-4534
111. Borra M.T., O'Neill F.J., Jackson M.D., Marshall B., Verdin E., Foltz K.R., and Denu J.M. Conserved enzymatic production and biological effect of O-acetyl-ADP-ribose by silent information regulator 2-like NAD+-dependent deacetylases. J. Biol. Chem. 277 (2002) 12632-12641
112. Grubisha O., Rafty L.A., Takanishi C.L., Xu X., Tong L., Perraud A.L., Scharenberg A.M., and Denu J.M. Metabolite of SIR2 reaction modulates TRPM2 ion channel. J. Biol. Chem. 281 (2006) 14057-14065
113. Kustatscher G., Hothorn M., Pugieux C., Scheffzek K., and Ladurner A.G. Splicing regulates NAD metabolite binding to histone macroH2A. Nat. Struct. Mol. Biol. 12 (2005) 624-625
114. Liou G.G., Tanny J.C., Kruger R.G., Walz T., and Moazed D. Assembly of the SIR complex and its regulation by O-acetyl-ADP-ribose, a product of NAD-dependent histone deacetylation. Cell 121 (2005) 515-527
115. Frye R.A. Characterization of five human cDNAs with homology to the yeast SIR2 gene: Sir2-like proteins (sirtuins) metabolize NAD and may have protein ADP-ribosyltransferase activity. Biochem. Biophys. Res. Commun. 260 (1999) 273-279
116. Garcia-Salcedo J.A., Gijon P., Nolan D.P., Tebabi P., and Pays E. A chromosomal SIR2 homologue with both histone NAD-dependent ADP-ribosyltransferase and deacetylase activities is involved in DNA repair in Trypanosoma brucei. EMBO J. 22 (2003) 5851-5862
117. Haigis M.C., Mostoslavsky R., Haigis K.M., Fahie K., Christodoulou D.C., Murphy A.J., Valenzuela D.M., Yancopoulos G.D., Karow M., Blander G., Wolberger C., Prolla T.A., Weindruch R., Alt F.W., and Guarente L. SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic beta cells. Cell 126 (2006) 941-954
118. Liszt G., Ford E., Kurtev M., and Guarente L. Mouse Sir2 homolog SIRT6 is a nuclear ADP-ribosyltransferase. J. Biol. Chem. 280 (2005) 21313-21320
119. Tanny J.C., Dowd G.J., Huang J., Hilz H., and Moazed D. An enzymatic activity in the yeast Sir2 protein that is essential for gene silencing. Cell 99 (1999) 735-745
120. Kowieski T.M., Lee S., and Denu J.M. Acetylation-dependent ADP-ribosylation by Trypanosoma brucei Sir2. J. Biol. Chem. 283 (2008) 5317-5326
121. Tanner K.G., Landry J., Sternglanz R., and Denu J.M. Silent information regulator 2 family of NAD-dependent histone/protein deacetylases generates a unique product, 1-O-acetyl-ADP-ribose. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 14178-14182
122. Michishita E., McCord R.A., Berber E., Kioi M., Padilla-Nash H., Damian M., Cheung P., Kusumoto R., Kawahara T.L., Barrett J.C., Chang H.Y., Bohr V.A., Ried T., Gozani O., and Chua K.F. SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin. Nature (2008)
123. Chen Y., Sprung R., Tang Y., Ball H., Sangras B., Kim S.C., Falck J.R., Peng J., Gu W., and Zhao Y. Lysine propionylation and butyrylation are novel post-translational modifications in histones. Mol. Cell. Proteomics 6 (2007) 812-819
124. Gill G. Something about SUMO inhibits transcription. Curr. Opin. Genet. Dev. 15 (2005) 536-541
125. Hassa P.O., Haenni S.S., Elser M., and Hottiger M.O. Nuclear ADP-ribosylation reactions in mammalian cells: where are we today and where are we going?. Microbiol. Mol. Biol. Rev. 70 (2006) 789-829
126. Shilatifard A. Chromatin modifications by methylation and ubiquitination: implications in the regulation of gene expression. Annu. Rev. Biochem. 75 (2006) 243-269
127. Hassan Y.I., and Zempleni J. Epigenetic regulation of chromatin structure and gene function by biotin. J. Nutr. 136 (2006) 1763-1765
128. Garrity J., Gardner J.G., Hawse W., Wolberger C., and Escalante-Semerena J.C. N-lysine propionylation controls the activity of propionyl-CoA synthetase. J. Biol. Chem. 282 (2007) 30239-30245
129. Smith B.C., and Denu J.M. Acetyl-lysine analog peptides as mechanistic probes of protein deacetylases. J. Biol. Chem. 282 (2007) 37256-37265
130. Bedford M.T., and Richard S. Arginine methylation an emerging regulator of protein function. Mol. Cell 18 (2005) 263-272
131. Wysocka J., Allis C.D., and Coonrod S. Histone arginine methylation and its dynamic regulation. Front. Biosci. 11 (2006) 344-355
132. Vossenaar E.R., Zendman A.J., van Venrooij W.J., and Pruijn G.J. PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease. Bioessays 25 (2003) 1106-1118
133. Hong H., Kao C., Jeng M.H., Eble J.N., Koch M.O., Gardner T.A., Zhang S., Li L., Pan C.X., Hu Z., MacLennan G.T., and Cheng L. Aberrant expression of CARM1, a transcriptional coactivator of androgen receptor, in the development of prostate carcinoma and androgen-independent status. Cancer 101 (2004) 83-89
134. Majumder S., Liu Y., Ford III O.H., Mohler J.L., and Whang Y.E. Involvement of arginine methyltransferase CARM1 in androgen receptor function and prostate cancer cell viability. Prostate 66 (2006) 1292-1301
135. Mastronardi F.G., Wood D.D., Mei J., Raijmakers R., Tseveleki V., Dosch H.M., Probert L., Casaccia-Bonnefil P., and Moscarello M.A. Increased citrullination of histone H3 in multiple sclerosis brain and animal models of demyelination: a role for tumor necrosis factor-induced peptidylarginine deiminase 4 translocation. J. Neurosci. 26 (2006) 11387-11396
136. Yue W.W., Hassler M., Roe S.M., Thompson-Vale V., and Pearl L.H. Insights into histone code syntax from structural and biochemical studies of CARM1 methyltransferase. EMBO J. 26 (2007) 4402-4412
137. Zhang X., Zhou L., and Cheng X. Crystal structure of the conserved core of protein arginine methyltransferase PRMT3. EMBO J. 19 (2000) 3509-3519
138. Zhang X., and Cheng X. Structure of the predominant protein arginine methyltransferase PRMT1 and analysis of its binding to substrate peptides. Structure 11 (2003) 509-520
139. Frankel A., Yadav N., Lee J., Branscombe T.L., Clarke S., and Bedford M.T. The novel human protein arginine N-methyltransferase PRMT6 is a nuclear enzyme displaying unique substrate specificity. J. Biol. Chem. 277 (2002) 3537-3543
140. Osborne T.C., Obianyo O., Zhang X., Cheng X., and Thompson P.R. Protein arginine methyltransferase 1: positively charged residues in substrate peptides distal to the site of methylation are important for substrate binding and catalysis. Biochemistry 46 (2007) 13370-13381
141. Klein S., Carroll J.A., Chen Y., Henry M.F., Henry P.A., Ortonowski I.E., Pintucci G., Beavis R.C., Burgess W.H., and Rifkin D.B. Biochemical analysis of the arginine methylation of high molecular weight fibroblast growth factor-2. J. Biol. Chem. 275 (2000) 3150-3157
142. Lischwe M.A., Cook R.G., Ahn Y.S., Yeoman L.C., and Busch H. Clustering of glycine and NG,NG-dimethylarginine in nucleolar protein C23. Biochemistry 24 (1985) 6025-6028
143. Lischwe M.A., Ochs R.L., Reddy R., Cook R.G., Yeoman L.C., Tan E.M., Reichlin M., and Busch H. Purification and partial characterization of a nucleolar scleroderma antigen (Mr = 34,000; pI, 8.5) rich in NG,NG-dimethylarginine. J. Biol. Chem. 260 (1985) 14304-14310
144. Smith J.J., Rucknagel K.P., Schierhorn A., Tang J., Nemeth A., Linder M., Herschman H.R., and Wahle E. Unusual sites of arginine methylation in Poly(A)-binding protein II and in vitro methylation by protein arginine methyltransferases PRMT1 and PRMT3. J. Biol. Chem. 274 (1999) 13229-13234
145. Troffer-Charlier N., Cura V., Hassenboehler P., Moras D., and Cavarelli J. Functional insights from structures of coactivator-associated arginine methyltransferase 1 domains. EMBO J. 26 (2007) 4391-4401
146. Weiss V.H., McBride A.E., Soriano M.A., Filman D.J., Silver P.A., and Hogle J.M. The structure and oligomerization of the yeast arginine methyltransferase, Hmt1. Nat. Struct. Biol. 7 (2000) 1165-1171
147. Miranda T.B., Miranda M., Frankel A., and Clarke S. PRMT7 is a member of the protein arginine methyltransferase family with a distinct substrate specificity. J. Biol. Chem. 279 (2004) 22902-22907
148. Higashimoto K., Kuhn P., Desai D., Cheng X., and Xu W. Phosphorylation-mediated inactivation of coactivator-associated arginine methyltransferase 1. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 12318-12323
149. Tang J., Gary J.D., Clarke S., and Herschman H.R. PRMT 3, a type I protein arginine N-methyltransferase that differs from PRMT1 in its oligomerization, subcellular localization, substrate specificity, and regulation. J. Biol. Chem. 273 (1998) 16935-16945
150. Chang B., Chen Y., Zhao Y., and Bruick R.K. JMJD6 is a histone arginine demethylase. Science 318 (2007) 444-447
151. Das K., Butler G.H., Kwiatkowski V., Clark Jr. A.D., Yadav P., and Arnold E. Crystal structures of arginine deiminase with covalent reaction intermediates; implications for catalytic mechanism. Structure 12 (2004) 657-667
152. Luo Y., Arita K., Bhatia M., Knuckley B., Lee Y.H., Stallcup M.R., Sato M., and Thompson P.R. Inhibitors and inactivators of protein arginine deiminase 4: functional and structural characterization. Biochemistry 45 (2006) 11727-11736
153. Luo Y., Knuckley B., Lee Y.H., Stallcup M.R., and Thompson P.R. A fluoroacetamidine-based inactivator of protein arginine deiminase 4: design, synthesis, and in vitro and in vivo evaluation. J. Am. Chem. Soc. 128 (2006) 1092-1093
154. Knuckley B., Bhatia M., and Thompson P.R. Protein arginine deiminase 4: evidence for a reverse protonation mechanism. Biochemistry 46 (2007) 6578-6587
155. Galkin A., Lu X., Dunaway-Mariano D., and Herzberg O. Crystal structures representing the Michaelis complex and the thiouronium reaction intermediate of Pseudomonas aeruginosa arginine deiminase. J. Biol. Chem. 280 (2005) 34080-34087
156. Arita K., Hashimoto H., Shimizu T., Nakashima K., Yamada M., and Sato M. Structural basis for Ca(2+)-induced activation of human PAD4. Nat. Struct. Mol. Biol. 11 (2004) 777-783
157. Kearney P.L., Bhatia M., Jones N.G., Yuan L., Glascock M.C., Catchings K.L., Yamada M., and Thompson P.R. Kinetic characterization of protein arginine deiminase 4: a transcriptional corepressor implicated in the onset and progression of rheumatoid arthritis. Biochemistry 44 (2005) 10570-10582
158. Dong Z., Saikumar P., Weinberg J.M., and Venkatachalam M.A. Calcium in cell injury and death. Annu. Rev. Pathol. 1 (2006) 405-434
159. Thompson P.R., and Fast W. Histone citrullination by protein arginine deiminase: is arginine methylation a green light or a roadblock?. ACS Chem. Biol. 1 (2006) 433-441
160. Cuthbert G.L., Daujat S., Snowden A.W., Erdjument-Bromage H., Hagiwara T., Yamada M., Schneider R., Gregory P.D., Tempst P., Bannister A.J., and Kouzarides T. Histone deimination antagonizes arginine methylation. Cell 118 (2004) 545-553
161. Wang Y., Wysocka J., Sayegh J., Lee Y.H., Perlin J.R., Leonelli L., Sonbuchner L.S., McDonald C.H., Cook R.G., Dou Y., Roeder R.G., Clarke S., Stallcup M.R., Allis C.D., and Coonrod S.A. Human PAD4 regulates histone arginine methylation levels via demethylimination. Science 306 (2004) 279-283
162. Raijmakers R., Zendman A.J., Egberts W.V., Vossenaar E.R., Raats J., Soede-Huijbregts C., Rutjes F.P., van Veelen P.A., Drijfhout J.W., and Pruijn G.J. Methylation of arginine residues interferes with citrullination by peptidylarginine deiminases in vitro. J. Mol. Biol. 367 (2007) 1118-1129
163. Cosgrove M.S., and Wolberger C. How does the histone code work?. Biochem. Cell. Biol. 83 (2005) 468-476
164. Jenuwein T., and Allis C.D. Translating the histone code. Science 293 (2001) 1074-1080
165. Schreiber S.L., and Bernstein B.E. Signaling network model of chromatin. Cell 111 (2002) 771-778
166. Tang Y., Holbert M.A., Wurtele H., Meeth K., Rocha W., Gharib M., Jiang E., Thibault P., Verrault A., Cole P.A., and Marmorstein R. Fungal Rtt109 histone acetyltransferase is an unexpected structural homolog of metazoan p300/CBP. Nat. Struct. Mol. Biol. 15 (2008) 738-745